Identifying essential information to support patient decision-making regarding participation in cancer clinical trials: A Delphi study.

The 15 essential statements identified in this study could be used as components of a summarised information sheet given to potential cancer clinical trial participants, as an adjunct to the informed consent process. A robust evaluation of the impact of these statements on the quality of the informed consent process is needed.